IntegraGen , a company specializing in the decryption of the human genome, which performs interpretable genomic analyzes for academic and private laboratories, and the Institut Pasteur, an institution recognized for public utility, whose mission is notably the prevention and fight against infectious diseases, by research, teaching and public health actions, today announced the renewal of an agreement through December 2021 related to IntegraGen’s provision of high-throughput sequencing services for microbiology.
Through the renewal of the original agreement, which was signed in 2015, IntegraGen will continue its activities as operator of the P2M platform (Mutualized Microbiology Platform) for sequencing microorganisms for the National Reference Centers (CNR) hosted by the Institut Pasteur. This includes performing the daily technical sequencing operations essential for typing the strains organisms received by the CNR for the Institute and enabling the Institut Pasteur’s scientists to receive data based on the latest sequencing methods.
Vincent Enouf, Director of the P2M platform P2M, stated: “Over the past five years, we have demonstrated our joint ability to provide National Reference Centers with a very efficient service for producing high-throughput sequencing data for microbiology samples, with tens of thousands DNA results obtained for both public health use and research applications. We are pleased to be able to continue this collaboration and benefit from IntegraGen’s sequencing expertise and support for our efforts.”
Bernard Courtieu, CEO of IntegraGen, added: “We are particularly proud of the work we have accomplished over the past five years with the teams at the Institut Pasteur, a world reference for microbiology for more than a century. We are delighted to be able to continue our collaboration with the P2M teams where our services are increasing need and where the control of quality, deadlines and costs remains fundamental.”